Govt may lift ban on online sale of meds


The government is likely to lift the temporary ban on online sale of medicines following an expert committee's recommendations that keeping prescription drugs out of the online platform may be unfair to consumers in present times.

Clearing the roadmap for resuming online sale of medicines that had been banned around a year ago, the Drugs Consultative Committee has submitted its report to the drug regulator -Drugs Controller General of India (DCGI).“We are in the process of adding our comments to the report and will forward it to the health ministry in the next few days,” a senior official in the DCGI's office told TOI.

However, the committee has suggested a number of safeguards, including a legal framework and maintenance of prescription record, while allowing sale of medicines online, the official said while indicating the general consensus in the government as well as among regulators to allow sale of medicines through e-commerce platforms.

The suggestions made by the committee include formation of a central portal to register all e-pharmacies, creating an ecosystem as well as introduction of detailed rules and regulations under the existing Drugs and Cosmetics Act to bring any violation to books. It has also recommended formation of an inter-ministerial committee to deliberate on the rules and a detailed legal framework, the official said.

In May last year, the government had asked the drug regulator to draft guidelines and introduce provisions in the law to monitor and regulate online sale of medicines. However, the regular chemists and pharmacists opposed the move and went on a daylong strike across the country in October 2015 to protest against allowing online sale of medicines. The retailers argued that online sales is not in public interest and may result in misuse of drugs. This led to the government imposing a temporary suspension on online sale of prescription drugs and setting up a committee to evaluate the issue.

Detailed deliberations have been made and though there are risks involved, experts are of the view that it is difficult and unfair to not allow e-pharmacies. However, proper monitoring and regulation is essential,” the official said.

Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

WhatsApp Group for Pharma Literati